CA2019324A1 - Comprimes de fosinopril - Google Patents

Comprimes de fosinopril

Info

Publication number
CA2019324A1
CA2019324A1 CA2019324A CA2019324A CA2019324A1 CA 2019324 A1 CA2019324 A1 CA 2019324A1 CA 2019324 A CA2019324 A CA 2019324A CA 2019324 A CA2019324 A CA 2019324A CA 2019324 A1 CA2019324 A1 CA 2019324A1
Authority
CA
Canada
Prior art keywords
tablet formulations
fosinopril
fosinopril tablet
tablets
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2019324A
Other languages
English (en)
Other versions
CA2019324C (fr
Inventor
Robert L. Jerzewski
Thomas M. Wong
Lewis J. Gryziewicz
Nemichand B. Jain
Ajit B. Thakur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2019324A1 publication Critical patent/CA2019324A1/fr
Application granted granted Critical
Publication of CA2019324C publication Critical patent/CA2019324C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002019324A 1989-07-10 1990-06-19 Comprimes de fosinopril Expired - Lifetime CA2019324C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37768389A 1989-07-10 1989-07-10
US377,683 1989-07-10

Publications (2)

Publication Number Publication Date
CA2019324A1 true CA2019324A1 (fr) 1991-01-10
CA2019324C CA2019324C (fr) 1996-08-20

Family

ID=23490122

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002019324A Expired - Lifetime CA2019324C (fr) 1989-07-10 1990-06-19 Comprimes de fosinopril

Country Status (8)

Country Link
EP (1) EP0408273B1 (fr)
JP (1) JP2965633B2 (fr)
AT (1) ATE100321T1 (fr)
CA (1) CA2019324C (fr)
DD (1) DD299154A5 (fr)
DE (1) DE69006125T2 (fr)
DK (1) DK0408273T3 (fr)
ES (1) ES2062376T3 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9993434B2 (en) 2003-07-31 2018-06-12 Delavau L.L.C. Calcium carbonate granulation

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679451B1 (fr) * 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
FR2784895B1 (fr) * 1998-10-23 2004-12-17 Gattefosse Ets Sa Comprime a croquer a gout masque et liberation immediate du principe actif et procede de fabrication
CA2352430C (fr) * 1998-12-01 2008-11-18 Novo Nordisk A/S Nouvelle composition pharmaceutique et procede de preparation
CA2363053C (fr) * 2001-11-09 2011-01-25 Bernard Charles Sherman Formulation pour pastilles de bisulfate de clopidogrel
KR20010114199A (ko) * 2001-12-11 2001-12-29 유형선 제약산업에서 사용될 수 있는 고형제제를 위한 직타용부형제의 새로운 의약품 조성물
US20050095287A1 (en) * 2003-10-29 2005-05-05 Matharu Amol S. Fosinopril composition
EP1819323B2 (fr) * 2004-12-03 2023-03-22 Merck Sharp & Dohme Corp. Composition pharmaceutique renfermant un agent d'anti-nucleation
GR1006875B (el) * 2005-06-30 2010-07-12 "Φαρματεν" Φαρμακευτικη Βιομηχανικη Εμπορικη Α.Ε., Βελτιωμενες φαρμακευτικες συνθεσεις περιεχουσες αναστολεις του μετατρεπτικου ενζυμου αγγειοτενσινης και μεθοδοι παρασκευης αυτων.
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217347A (en) * 1977-12-27 1980-08-12 E. R. Squibb & Sons, Inc. Method of treating hypertension and medicaments therefor
US4384123A (en) * 1980-12-04 1983-05-17 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl substituted prolines
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
CA1321753C (fr) * 1987-04-27 1993-08-31 Abraham Sudilovsky Methode permettant d'empecher la perte des fonctions cognitives a l'aide d'un inhibiteur de l'enzyme de conversion

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9993434B2 (en) 2003-07-31 2018-06-12 Delavau L.L.C. Calcium carbonate granulation

Also Published As

Publication number Publication date
EP0408273B1 (fr) 1994-01-19
JP2965633B2 (ja) 1999-10-18
DD299154A5 (de) 1992-04-02
EP0408273A1 (fr) 1991-01-16
CA2019324C (fr) 1996-08-20
DE69006125T2 (de) 1994-05-19
JPH0348623A (ja) 1991-03-01
ATE100321T1 (de) 1994-02-15
DK0408273T3 (da) 1994-02-28
DE69006125D1 (de) 1994-03-03
ES2062376T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
CA2019324A1 (fr) Comprimes de fosinopril
AU5431390A (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
AU1399492A (en) Remedies for bone diseases
GB2138290B (en) Divisible polyacrylate-based tablet
AU1056795A (en) Removable, washable sweatband for hats
DE3779053D1 (fr)
GR3007385T3 (fr)
DE68903424D1 (en) Antioxidant.
WO1991001958A3 (fr) 11β-ARYL-GONA-4,9-DIENE-3-ONES
ZA874196B (en) Anti-inflammatory compositions
DE69019035D1 (de) Stabilisierte fettlösliche Vitaminzusammensetzungen.
AU5494490A (en) 3,4-dehydropiperidine derivatives having psychotropic activity
DE59001121D1 (en) Antacidatabletten.
GB2204239B (en) Ophthalmic composition.
GR3015016T3 (en) Ultra-wideband achromatic lens.
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
AU567940B2 (en) Controlled release tablet
NZ219259A (en) Pharmaceutical compositions containing glycerophosphoryl-o-serine and its salts
ES2185666T3 (es) Formulacion estabilizada para comprimidos.
AU4719489A (en) Controlled-release, low dose aspirin
CA2330904A1 (fr) Formulation pour pastilles de fosinopril sodium
EP0948961A3 (fr) Comprimé effervescent comprenant du calcium avec un antihistaminique comme principe actif
EP0300036A4 (fr) Compositions pharmaceutiques a base de vasopressine.
AU8184291A (en) 1,4-benzodioscane derivatives, process for the preparation thereof and pharmaceutical compositions therefrom
AU4379889A (en) Desk height adjustment mechanism

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry
MKEX Expiry

Effective date: 20100619